Preview

Онкоурология

Расширенный поиск

Цитоморфологическая классификация уринарной патологии. Парижская система 2016 г.

https://doi.org/10.17650/1726-9776-2016-12-4-110-118

Полный текст:

Аннотация

В работе представлена Парижская система оценки уринарной цитопатологии, разработанная совместными усилиями цитологов, патологов и урологов в апреле 2016 г. Показаны 7 принятых категорий цитологических заключений, риск выявления злокачественной опухоли и рекомендуемая тактика ведения пациентов при уринарной патологии.

Об авторах

М. В. Савостикова
ФГБУ «Российский онкологический научный центр им. Н.Н. Блохина» Минздрава России
Россия
115478 Москва, Каширское шоссе, 23


А. Г. Кудайбергенова
ФГБУ «Российский онкологический научный центр им. Н.Н. Блохина» Минздрава России
115478 Москва, Каширское шоссе, 23


Е. С. Федосеева
ФГБУ «Российский онкологический научный центр им. Н.Н. Блохина» Минздрава России
Россия
115478 Москва, Каширское шоссе, 23


Список литературы

1. Статистика злокачественных новообразований в России и странах СНГ в 2012 году. Под ред. М.И. Давыдова, Е.М. Аксель. М.: Издательская группа РОНЦ, 2014. 226 с. [Statistics of malignant tumors in Russia and CIS countries in 2012. Eds. by: М.I. Davydov, Е.М. Аksel’. Мoscow: Izdatel’skaya gruppa RONTS, 2014. 226 p. (In Russ.)].

2. Amin M.B., Smith S.C., Reuter V.E. et al. Update for the practicing pathologist: the International Consultation On Urologic Disease-European association of urology consultation on bladder cancer. Mod Pathol 2014;28(5)1–19. PMID: 25412849. PMCID: PMC5009623. DOI: 10.1038/modpathol.2014.158.

3. Rosenthal D.L., Wojcik E.M., Kurtycz D.F.I. The Paris System for reporting urinary cytology. Springer, 2016.

4. Galed-Placed I., Valbuena-Ruvira L. Decoy cells and malignant cells coexisting in the urine from a transplant recipient with BK virus nephropathy and bladder adenocarcinoma. Diagn Cytopathol 2011;39(12):933–7. PMID: 22081531. DOI: 10.1002/dc.21579.

5. Geetha D., Tong B.C., Racusen L. et al. Bladder carcinoma in a transplant recipient: evidence to implicate the BK human polyomavirus as a causal transforming agent. Transplantation 2002;73(12):1933–6. PMID: 12131691.

6. Wojcik E.M. What should not be reported as atypia in urine cytology. J Am Soc Cytopathol 2015;4:30–6.

7. Piaton E., Decaussin-Petrucci M., MegeLechevallier F. et al. Diagnostic terminology for urinary cytology reports including the new subcategories “atypical urothelial cells of undetermined significance” (AUC-US) and “cannot exclude high grade” (AUC-H). Cytopathology 2014;25:27–38.

8. Sternberg I., Rona R., Olsfanger S. et al. The clinical significance of class III (suspicious) urine cytology. Cytopathology 2011;22(5):329–33. PMID: 21114557. DOI: 10.1111/j.1365-2303.2010.00827.x.

9. Vanden Bussche C.J., Sathiyamoorthy S., Owens C.L. et al. The Johns Hopkins Hospital template for urologic cytology samples: parts II and III: improving the predictability of indeterminate results in urinary cytologic samples: an outcomes and cytomorphologic study. Cancer Cytopathol 2013;121(1):21–8. PMID: 23192913. DOI: 10.1002/cncy.21254.

10. Ton Nu T.N., Kassouf W., Ahmadi-Kaliji B. et al. The value of the “suspicious for urothelial carcinoma” cytology category: a correlative study of 4 years including 337 patients. Cancer Cytopathol 2014;122(11):796–803. PMID: 24909774. DOI: 10.1002/cncy.21449.

11. Murphy W.M., Soloway M.S., Jukkola A.F. et al. Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms. Cancer 1984;53(7):1555–65. PMID: 6697294.

12. Raab S.S., Lenel J.C., Cohen M.B. Low grade transitional cell carcinoma of the bladder. Cytologic diagnosis by key features as identified by logistic regression analysis. Cancer 1994;74(5):1621–6. PMID: 8062194.

13. Hughes J.H., Raab S.S., Cohen M.B. The cytologic diagnosis of low-grade transitional cell carcinoma. Am J Clin Pathol 2000;114:59–67. PMID: 11996171.

14. Xin W., Raab S.S., Michael C.W. Lowgrade urothelial carcinoma: reappraisal of the cytologic criteria on ThinPrep. Diagn Cytopathol 2003;29(3):125–9. PMID: 12951678. DOI: 10.1002/dc.10311.

15. Mai K.T., Ball C.G., Kos Z. et al. Threedimensional cell groups with disordered nuclei and cellular discohesion (3DDD) are associated with high sensitivity and specificity for cystoscopic urine cytopathological diagnosis of low-grade urothelial neoplasia. Diagn Cytopathol 2014;42(7):555–63. PMID: 24273035. DOI: 10.1002/dc.23069.

16. Nathan N.A., Narayan E., Smith M.M., Horn M.J. Cell block cytology. Improved preparation and its efficacy in diagnostic cytology. Am J Clin Pathol 2000;114(4): 599–606. PMID: 11026107. DOI: 10.1309/G035-P2MM-D1TM-T5QE.

17. Reid M.D., Osunkoya A.О., Siddiqui M.T., Looney S.W. Accuracy of grading of urothelial carcinoma on urine cytology: an analysis of in terobserver and intraobserver agreement. Int J Clin Exp Pathol 2012;5(9):882–91. PMID: 23119105. PMCID: PMC3484494.

18. Raab S.S., Grzybicki D.M., Vrbin C.M., Geisinger K.R. Urine cytology discrepancies: frequency, causes, and outcomes. Am J Clin Pathol 2007;127(6):946–53. PMID: 17509992. DOI: 10.1309/XUVXFXMFPL7TELCE.

19. Rosenthal D.L., Vandenbussche C.J., Burroughs F.H. et al. The Johns Hopkins Hospital template for urologic cytology samples: part I-creating the template. Cancer Cytopathol 2013;121(1):15–20. PMID: 23192944. DOI: 10.1002/cncy.21255.

20. Ubago J.M., Mehta V., Wojcik E.M., Barkan G.A. Evaluation of atypical urine cytology progression to malignancy. Cancer Cytopathol 2013;121(7):387–91. PMID: 23536358. DOI: 10.1002/cncy.21278.

21. Koss L.G., Hoda R.S. Koss’s cytology of the urinary tract with histopathology correlations. New York: Springer Press, 2012.

22. Hoda R.S. Non-gynecologic cytology on liquid-based preparations: 3 morphologic review of facts and artifacts. Diagn Cytopathol 2007;35(10):621–34. PMID: 17854077. DOI: 10.1002/dc.20698.

23. Khaled H. Schistosomiasis and cancer in Egypt review. J Adv Res 2013;4(5):461–6. PMID: 25685453. PMCID: PMC4293882. DOI: 10.1016/j.jare.2013.06.007.

24. Hattori M., Nishimura Y., Toyonaga M. et al. Cytological significance of abnormal squamous cells in urinary cytology. Diagn Cytopathol 2012;40(9):798–803. PMID: 21309015. DOI: 10.1002/dc.21645.

25. Gulmann C., Paner G.P., Parakh R.S. et al. Immunohistochemical profile to distinguish urothelial from squamous differentiation in carcinomas of urothelial tract. Hum Pathol 2013;44(2):164–72. PMID: 22995333. DOI: 10.1016/j.humpath.2012.05.018.

26. Zhong M., Gersbach E., Rohan S.M., Yang X.J. Primary adenocarcinoma of the urinary bladder: differential diagnosis and clinical relevance. Arch Pathol Lab Med 2013;137(3);371–81. PMID: 23451748. DOI: 10.5858/arpa.2012-0076-RA.

27. Bardales R.H., Pitman M.B., Stanley M.W. et al. Urine cytology of primary and secondary urinary bladder adenocarcinoma. Cancer 1998;84(6):335–43. PMID: 9915134.

28. Ciesla M.C., Guidos B.J., Selvaggi S.M. Cytomorphology of small-cell (neuroendocrine) carcinoma on Thin Prep cytology as compared to conventional smears. Diagn Cytopathol 2001;24(1):46–52. PMID: 11135469.

29. Dahm P., Gschwend J.E. Malignant nonurothelial neoplasms of the urinary bladder: a review. Eur Urol 2003;44(6):672–81. PMID: 14644119.

30. Chalasani V., Chin J.L., Izawa J.I. Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer. Can Urol Assoc J 2009;3(6 Suppl 4):193–8. PMID: 20019984. PMCID: PMC2792446.

31. Abol-Enein H., Kava B.R., Carmack A.J. Nonurothelial cancer of the bladder. Urology 2007;69(1 Suppl): 93–104.

32. Westfall D.E., Folpe A.L., Paner G.P. et al. Utility of a comprehensive immunohistochemical panel in the differential diagnosis of spindle cell lesions of the urinary bladder. Am J Surg Pathol 2009;33(1):99–105. PMID: 18941404. DOI: 10.1097/PAS.0b013e318180c899.

33. Cheson B.D., Schumann J.L., Schumann G.B. Urinary cytodiagnostic abnormalities in 50 patients with non-Hodgkin’s lymphomas. Cancer 1984;54(9):1914–9. PMID: 6478425.

34. Jimenez-Hernandez M., Lopez-Guillermo A., Cobo F. et al. Bladder involvement of diffuse large B-cell lymphoma diagnosed by a cytological study of the urine. Leuk Lymphoma 2002;43(1):187–9. PMID: 11908726. DOI: 10.1080/10428190210201.

35. Khalbuss W.E., Hossain M., Elhosseiny A. Primary malignant melanoma of the urinary bladder diagnosed by urine cytology: a case report. Acta Cytol 2001;45(4):631–5. PMID: 11480732.

36. Xiao G.Q., Chow J., Unger P.D. Metastatic tumors to the urinary bladder: clinic pathologic study of 11 cases. Int J Surg Pathol 2012;20(4):342–8. PMID: 22134629. DOI: 10.1177/1066896911428736.


Для цитирования:


Савостикова М.В., Кудайбергенова А.Г., Федосеева Е.С. Цитоморфологическая классификация уринарной патологии. Парижская система 2016 г. Онкоурология. 2016;12(4):110-118. https://doi.org/10.17650/1726-9776-2016-12-4-110-118

For citation:


Savostikova M.V., Kudaybergenova A.G., Fedoseeva E.S. The cytomorphologic classification of urinary pathology. The Paris System, 2016 Cancer Urology. 2016;12(4):110-118. (In Russ.) https://doi.org/10.17650/1726-9776-2016-12-4-110-118

Просмотров: 421


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1726-9776 (Print)
ISSN 1996-1812 (Online)